The payment card services provider is still an evergreen investment.
August’s stock market fiasco is a ‘stark red flag’ for what’s to come, veteran hedge funder warns
“These whips are the market process. This is the market zigging in order to zag.” Universa Investments' Mark Spitznagel told Fortune.
Jefferies Predicts up to 270% Rally for These 2 ‘Strong Buy’ Stocks
While inflation has eased to 2.9% in July, interest rates remain elevated, with the Federal Reserve’s key rate currently at 5.25% to 5.50%. However, it is widely expected that the Fed will begin cutting rates as early as next month. A reduction in rates is likely to send ripples across various sectors, with the biotech industry being particularly affected. Biotech companies, which often operate with significant overhead costs, are especially sensitive to changes in interest rates. But with a rat
Down 89%, Is It Time to Buy the Dip on This Growth Stock?
Investors can find compelling opportunities in beaten-down stocks.
Prediction: Rivian Stock Will Move on Emerging Catalysts
Rivian's next EV will drive the stock -- the question is in which direction.
Airbnb Sell-Off: Buy or Sell This Disruptive Tech Stock?
Investors are worried about a travel slowdown.